Basel-based biotech Nouscom has raised €67.5 million ($72.2 million) to bankroll its cancer vaccines as the eight-year-old company looks to capitalize on momentum in the field.
Prof. Carlo Marchetti – Independent Chairman
Carlo Michero – Independent Member
Paolo Fundarò – Chief Executive Officer
Federica Draghi – Member
Daniele Scarinci – Member
Copyright © 2023 XGEN Venture SGR S.p.A | Sede legale: Via Privata Giovannino de Grassi 11, 20123 Milano. Capitale sociale Euro 50.000,00. Numero di iscrizione al Registro Imprese di Milano Monza Lodi Brianza, Codice Fiscale e Partita IVA: 11840730961. Numero iscrizione Albo dei Gestori FIA 200.